Skip to Main Content

Paper Details

Genome-wide CRISPR screen reveals v-ATPase as a drug target to lower levels of ALS protein ataxin-2.
Cell Rep
12
2022
Author NameAffiliation
Michael C BassikStanford University School of Medicine
Michael C BassikStanford University School of Medicine
Aaron D GitlerStanford University School of Medicine
  • 1 - 3

Datasets

Release 1.2